Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables - Other (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Receivables - Other data on record, last reported at $7.0 million in Q2 2025.

  • For Q2 2025, Receivables - Other rose 71.52% year-over-year to $7.0 million; the TTM value through May 2025 reached $7.0 million, up 71.52%, while the annual FY2025 figure was $7.0 million, 71.52% up from the prior year.
  • Receivables - Other reached $7.0 million in Q2 2025 per LFCR's latest filing, up from $6.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $13.9 million in Q1 2022 and bottomed at $2.9 million in Q4 2023.
  • Average Receivables - Other over 5 years is $7.5 million, with a median of $6.6 million recorded in 2025.
  • Peak YoY movement for Receivables - Other: crashed 69.25% in 2023, then soared 96.48% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $12.6 million in 2021, then plummeted by 33.33% to $8.4 million in 2022, then plummeted by 65.48% to $2.9 million in 2023, then skyrocketed by 96.48% to $5.7 million in 2024, then grew by 22.48% to $7.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $7.0 million in Q2 2025, $6.1 million in Q1 2025, and $5.7 million in Q4 2024.